E-LIB Suche - Ergebnisse für: Engelhardt, Marc

1

Evaluation of a Covalent Library of Diverse Warheads (CovLi..:

Klett, Theresa ; Schwer, Martin ; Ernst, Larissa...
Drug Design, Development and Therapy. 18 (2024) - p. 2653-2679 , 2024

Link: https://doi.org/10.2147/..

2

Derazantinib alone and with atezolizumab in metastatic urot..:

Necchi, Andrea ; Ramlau, Rodryg ; Falcón González, Alejandro...
JNCI Cancer Spectrum. 8 (2024) 3 - p. , 2024

Link: https://doi.org/10.1093/..

3

Safety and anti-tumor activity of lisavanbulin administered..:

Joerger, Markus ; Hundsberger, Thomas ; Haefliger, Simon...
Investigational New Drugs. 41 (2023) 2 - p. 267-275 , 2023

Link: https://doi.org/10.1007/..

4

2531. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attain..:

Bhavnani, Sujata M ; Hammel, Jeffrey P ; Rinaldo, Anthony J...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

5

2785. Characterization of Methicillin-resistant Staphylococ..:

Mendes, Rodrigo E ; Duncan, Leonard R ; Kimbrough, John H...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

6

Post-hoc analysis of the safety and efficacy of isavuconazo..:

Hamed, Kamal ; Engelhardt, Marc ; Kovanda, Laura L....
Scientific Reports. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

7

2530. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attain..:

Bhavnani, Sujata M ; Hammel, Jeffrey P ; Rinaldo, Anthony J...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

8

1699. Safety and Outcomes of Isavuconazonium Sulfate for th..:

Arrieta, Antonio C ; Segers, Heidi ; Deville, Jaime G...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

9

2532. Pharmacokinetic-Pharmacodynamic Analyses for Ceftobip..:

Bhavnani, Sujata M ; Hammel, Jeffrey P ; Liolios, Kathryn...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

10

2561. Population Pharmacokinetic Analyses for Ceftobiprole ..:

Cammarata, Anthony P ; Litherland, Karine ; Safir, M Courtney...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

11

LB2302. Ceftobiprole Compared to Daptomycin With or Without..:

Holland, Thomas L ; Cosgrove, Sara E ; Doernberg, Sarah B...
Open Forum Infectious Diseases. 9 (2022) Supplement_2 - p. , 2022

Link: https://doi.org/10.1093/..

12

APost HocAnalysis of Two Phase III Trials Showing the Effic..:

Huang, Haihui ; Gao, Lei ; Engelhardt, Marc..
Future Microbiology. 16 (2021) 11 - p. 783-796 , 2021

Link: https://doi.org/10.2217/..

13

Efficacy and Safety of Ceftobiprole in Patients Aged 65 yea..:

Welte, Tobias ; Scheeren, Thomas WL ; Overcash, J Scott...
Future Microbiology. 16 (2021) 8 - p. 543-555 , 2021

Link: https://doi.org/10.2217/..

14

1149. Baseline Chest CT Findings in Patients with Pulmonary..:

Hamed, Kamal ; Engelhardt, Marc ; Saulay, Mikael.
Open Forum Infectious Diseases. 7 (2020) Supplement_1 - p. S601-S602 , 2020

Link: https://doi.org/10.1093/..

15

Phase 1/2a trial of intravenous BAL101553, a novel controll..:

Kristeleit, Rebecca ; Evans, Jeffry ; Molife, L. Rhoda...
British Journal of Cancer. 123 (2020) 9 - p. 1360-1369 , 2020

Link: https://doi.org/10.1038/..